Part II: New Medications for Hepatitis C

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
1,584
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on May 16, 2011

Hugo Vargas, M.D., and Chair of Transplant Medicine at Mayo Clinic in Arizona discusses Boceprevir, a recently FDA approved therapy to treat Hepatitis C, and the anticipated FDA approval of telaprevir.

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (4)

Sign In or Sign Up now to post a comment!
  • Thank you very much for these videos, I am a hep c patient advocate and I have embedded these on our website, Hep C Out Of Bounds

  • GBU all..

  • Incivek is 2nd new hepatitis C drug cleared this month. On May 13, the FDA approved Victrelis, which works the same way as Incivek and is also taken with the older medicines.

  • Incivek offers the potential of cutting the treatment duration to 24 weeks for many patients, while Victrelis can cut treatment down to 28 weeks for some. Incivek, a pill also known as telaprevir, is poised to help transform treatment of hepatitis C by nearly doubling the chances of curing the serious liver disease compared with current standard treatments.

Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more